ascopubs.org

B-cell maturation antigen (BCMA) immunohistochemistry (IHC) staining in multiple myeloma (MM) patients with prior use of BCMA-based therapies.

Exploring nationwide trends in multiple myeloma (MM), autologous stem cell transplants (ASCTs), chimeric antigen receptor T-cell (CAR-T) therapy and coronavirus disease 2019 (COVID-19) in ...
ascopubs.org

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

Immunohistochemistry (IHC) is a newer technique for assessing the estrogen receptor (ER) status of breast cancers, with the potential to overcome many of the shortcomings associated with the ...
Precision Medicine Online

AI Tools Stumped By HER2-Low Breast Cancer Just Like Pathologists, Study Finds

A study evaluated agreement between 10 AI digital pathology tools in assessing IHC-based HER2 expression and found the most variability in identifying HER2-low samples.
News Medical

AI tool enhances cancer diagnosis by transforming standard tissue images

New AI-driven tool converts common histology images into detailed, multi-layered cancer markers, promising faster, more accurate diagnostics and improved patient outcomes. Study: Accelerating ...
The Scientist

Leica Biosystems Launches ChromoPlex III Detection System to Streamline Chromogenic Multiplex IHC for Reproducible, Digital-Ready Staining

Leica Biosystems, a global leader in anatomic and digital pathology solutions, today unveiled ChromoPlex III Triple Detection RUO, a chromogenic multiplex immunohistochemistry detection system ...